Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes.
Barbara Manzanares-MartinArancha CebriánLaura Del Puerto-NevadoRafael GonzálezSonia SolanesMaria Auxiliadora Gómez-EspañaJesús García-FoncillasEnrique ArandaPublished in: Journal for immunotherapy of cancer (2021)
NCT01450319, EudraCT 2010-023580-18.